Article Text
Abstract
Green bioethics is an area of research and scholarship that examines the impact of healthcare practices and policies on the environment and emphasises environmental values, such as ecological sustainability and stewardship. Some green bioethicists have argued that healthcare providers should inform patients about the environmental impacts of treatments and advocate for options that minimise adverse impacts. While disclosure of information pertaining to the environmental impacts of treatments could facilitate autonomous decision-making and strengthen the patient–provider relationship in situations where patients have clearly expressed environmental concerns, it may have the opposite effect in other situations if makes patients feel like they are being judged or manipulated. We argue, therefore, that there is not a generalisable duty to disclose environmental impact information to all patients during the consent process. Providers who practice green bioethics should focus on advocating for system-level changes in healthcare financing, organisation and delivery and use discretion when bringing up environmental concerns in their encounters with patients.
- Informed Consent
- Ethics- Medical
- Environment
- Personal Autonomy
- Politics
Data availability statement
No data are available.
Statistics from Altmetric.com
Data availability statement
No data are available.
Footnotes
Contributors Both authors conceived of the idea and arguments in this paper and drafted the manuscript. Both authors take full responsiblity for the work.
Funding This study was funded by National Institute of Environmental Health Sciences (ZIAES102646-10). It does not represent the views of the NIEHS, NIH, or US government,
Competing interests None declared.
Provenance and peer review Not commissioned; externally peer reviewed.
Read the full text or download the PDF:
Other content recommended for you
- Costs of switching to low global warming potential inhalers. An economic and carbon footprint analysis of NHS prescription data in England
- Barriers to green inhaler prescribing: ethical issues in environmentally sustainable clinical practice
- Towards net zero: asthma care
- Carbon footprint impact of the choice of inhalers for asthma and COPD
- Individual and community level predictors of women’s autonomy in health care decision-making among youth in East African countries: a multilevel analysis
- Environmental impact of inhalers for respiratory diseases: decreasing the carbon footprint while preserving patient-tailored treatment
- Turning green: the impact of changing to more eco-friendly respiratory healthcare – a carbon and cost analysis of Dutch prescription data
- The president speaks: prevention is best: lessons from protecting the ozone layer
- P187 Ease of use, effectiveness and environmental impacts: Evaluating inhaler prescriptions, patient preferences and opportunities for improvement
- Reducing carbon footprint of inhalers: analysis of climate and clinical implications of different scenarios in five European countries